CRBG vs MET

For growth investors, MetLife, Inc.

(MET) is the stronger pick with 10. 2% revenue growth year-over-year, versus 7. 9% for Corebridge Financial, Inc. (CRBG). MetLife, Inc. (MET) offers the better valuation at 16. 3x trailing P/E (7. 9x forward), making it the more compelling value choice. Analysts rate Corebridge Financial, Inc. (CRBG) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Corebridge Financial, Inc.

is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Corebridge Financial, Inc.

(CRBG) delivered a total return of +57. 3%, compared to +33. 2% for MetLife, Inc. (MET). Over 10 years, the gap is even starker: MET returned +152. 0% versus CRBG's +57. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), MetLife, Inc.

(MET) is the lower-risk stock at 1. 07β versus Corebridge Financial, Inc. 's 1. 49β — meaning CRBG is approximately 39% more volatile than MET relative to the S&P 500. On balance sheet safety, MetLife, Inc. (MET) carries a lower debt/equity ratio of 70% versus 78% for Corebridge Financial, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), MetLife, Inc.

(MET) is pulling ahead at 10. 2% versus 7. 9% for Corebridge Financial, Inc. (CRBG). On earnings-per-share growth, the picture is similar: MetLife, Inc. grew EPS -19. 2% year-over-year, compared to -118. 3% for Corebridge Financial, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

MetLife, Inc.

(MET) is the more profitable company, earning 4. 4% net margin versus -12. 7% for Corebridge Financial, Inc. — meaning it keeps 4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MET leads at 6. 0% versus -18. 7% for CRBG. At the gross margin level — before operating expenses — CRBG leads at 80. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Corebridge Financial, Inc.

(CRBG) trades at 5. 6x forward P/E versus 7. 9x for MetLife, Inc. — 2. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MET: 24. 7% to $97. 33.

All stocks in this comparison pay dividends.

Corebridge Financial, Inc. (CRBG) offers the highest yield at 3. 5%, versus 2. 9% for MetLife, Inc. (MET).

For long-horizon retirement investors, MetLife, Inc.

(MET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 07), 2. 9% yield, +152. 0% 10Y return). Both have compounded well over 10 years (MET: +152. 0%, CRBG: +57. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CRBG is a mid-cap income-oriented stock; MET is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.